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Carbon and nitrogen are two basic nutrient sources for cellular organisms. They supply precursors for
energy metabolism and metabolic biosynthesis. In the yeast Saccharomyces cerevisiae, distinct sensing and
signaling pathways have been described that regulate gene expression in response to the quality of carbon and
nitrogen sources, respectively. Gln3 is a GATA-type transcription factor of nitrogen catabolite-repressible
(NCR) genes. Previous observations indicate that the quality of nitrogen sources controls the phosphorylation
and cytoplasmic retention of Gln3 via the target of rapamycin (TOR) protein. In this study, we show that
glucose also regulates Gln3 phosphorylation and subcellular localization, which is mediated by Snf1, the yeast
homolog of AMP-dependent protein kinase and a cytoplasmic glucose sensor. Our data show that glucose and
nitrogen signaling pathways converge onto Gln3, which may be critical for both nutrient sensing and starvation
responses.
Carbon and nitrogen are the two most basic nutrient sources
for cellular organisms. They are used to produce energy and
synthesize a wide range of biomolecules. Energy metabolism
and metabolic biosynthesis are carried out by some 500 indi-
vidual chemical reactions, which are well organized along the
centrally placed glycolysis and tricarboxylic acid (TCA) cycle
(1). Individual reactions are well calibrated by a feedback reg-
ulation, which fine-tunes the flux of metabolites through a
particular pathway by temporarily increasing or decreasing the
activity of crucial enzymes. In response to the quality of carbon
and nitrogen, cells can also regulate the expression of genes
involved in different metabolic pathways, particularly those
involved in utilization and transport of the available nutrients.
Genetic analysis in budding yeast led to the identification of
signaling pathways that detect the quality of nutrients and
regulate gene expression. In the presence of high-quality ni-
trogen compounds such as glutamine, the expression of genes
necessary for utilization and transport of poor nitrogen sources
such as glutamate is repressed. These genes become dere-
pressed in a poor nitrogen source such as glutamate or during
nitrogen starvation. This phenomenon is called nitrogen catab-
olite repression (NCR) (reviewed in references 24 and 33).
Likewise, the presence of glucose represses the expression of
genes involved in transport and utilization of other carbon
sources. This is commonly known as glucose repression (re-
viewed in references 8 and 21).
A number of NCR transcription factors have now been iden-
tified, including the GATA-type transcription factors Gln3 and
Gat1/Nil1 (13, 16, 42). Recent studies have shed light on the
regulatory events leading to activation of Gln3. Tor1 and Tor2
are the yeast targets of rapamycin proteins (6, 28) and key
players of nutrient-mediated signal transduction (recently re-
viewed in references 17, 29, and 37–39). Both TOR proteins
interact with Gln3 and Gat1/Nil1 (3) and control their phos-
phorylation (2, 3, 9). Nitrogen starvation or inhibition of TOR
by rapamycin causes rapid dephosphorylation and nuclear ac-
cumulation of Gln3 (2, 3, 9), as well as expression of a wide
variety of NCR genes (3, 7, 23, 41). The Tap42-Sit4 phospha-
tase complex also appears to be involved in the regulation of
Gln3. tap42-11, a gain-of-function mutation (18) was found to
confer moderate (3) to complete (2) resistance to rapamycin in
Gln3 dephosphorylation. Ure2 is a yeast preprion protein that
acts as an inhibitor of Gln3 (14, 44). Depletion of Ure2 causes
constitutive nuclear accumulation of Gln3 (2, 3, 27). However,
the precise roles of Tap42-Sit4 and Ure2 remain to be further
defined.
Glucose repression is mediated by the intracellular glucose
sensor Snf1, a yeast homolog of AMP-activated protein kinase
(AMPK), and becomes activated when the glucose level is low
(recently reviewed in references 8, 21, and 22). Snf1 phosphor-
ylates and negatively regulates Mig1, a transcriptional repres-
sor involved in the utilization of alternative carbon sources (34,
43). A second class of glucose sensors is involved in the glucose
induction mechanism. Rgt2 and Snf3 are two plasma mem-
brane proteins with strong sequence similarity to hexose trans-
porters (HXT). However, they act as high- and low-glucose
sensors, respectively, to activate transcription of HXT genes in
response to extracellular glucose levels (reviewed in reference
35). Snf3 and Rgt2 do not appear to be involved in the general
glucose repression mechanism (31, 36).
Several studies indicate that not only nitrogen, but also car-
bon nutrient, controls the expression of some NCR genes (15,
41). However, it is not clear how carbon signaling cross talks
with the NCR pathway. In this study, we found that glucose
availability regulates Gln3 phosphorylation and subcellular lo-
calization via the Snf1 AMPK pathway. Thus, like mitogenic
signal transduction pathways, nutrient signaling pathways can
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closely interact with each other. Such interplay between two
key nutrient sensing and signaling pathways may be important
for cells to rapidly adjust cellular metabolic activities as well as
growth and proliferation in response to changing nutrient con-
ditions.
MATERIALS AND METHODS
Strains and plasmids. The following yeast strains were used in this study:
AH109 (MATa trp1-901 leu2-3 11 ura3-52 his3-200 gal4 gal80 LYS2::
Gal1UAS-Gal1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 ura3::MEL1UAS-
MEL1TATA-lacZ) (Clontech), SZy145 (MATa hisD1 leu2DO met15DO ura3D
ure2D::KanMx) (3), SZy158 (MATa ade2::hisG his3D200 leu2 D0 lysD0 met15D0
trp1D63 ura3D0 GLN3-Myc9-TRP1 (3), SZy215 (MATa hisD1 leu2DO met15DO
ura3DO) (3), SZy159 (MATa hisD1 leu2DO met15DO ura3DO gln3D::KanMx)
(3), SZy686 (MATa hisD1 leu2DO met15DO ura3DO snf1D::KanMx) (this study),
SZy687 (MATa hisD1 leu2DO met15DO ura3DO rgt2D::KanMx (this study),
SZy688 (MATa hisD1 leu2DO met15DO ura3DO snf3D::KanMx) (this study),
SZy812 (MATa hisD1 leu2DO met15DO ura3DO snf4D::KanMx (this study),
SZy813 (MATa hisD1 leu2DO met15DO ura3DO snf8D::KanMx (this study),
JC423 (MATa ura3-52 ade2-101oc his4-539am snf1D3 SUC2) (10), JC424
(MATa ura3-52 ade2-101 lys2-801 leu2::his3 snf1D Suc2) (10), and JC426 (MATa
ura3-52 his3-52 hisD200 ade2-101 lys2-801 trp1-903 tyr1-501 reg1D::Leu2) (20).
The other SZy strains were derived from SZy215 by the single-step PCR-based
deletion of the entire open reading frames as described before (5). The origins
of other strains are described as above. To analyze Gln3 phosphorylation and
localization, pRS315-GLN3-MYC9 and pRS416-GLN3-MYC9, the chromosomal
GLN3-MYC9 gene and its natural promoter were generated by PCR from
genomic DNA prepared from the GLN3-MYC9 strain (9) and cloned into
pRS315 or pRS416. The resulting plasmids were transformed into yeast, shown
to express Gln3-MYC9 at a level comparable to that of the chromosomal GLN3-
MYC9 gene as judged by Western blotting. Both full-length GLN3 and SNF1
were amplified by PCR and cloned into pACT2 and pAS2–1, respectively (Clon-
tech). The yeast two-hybrid assays were performed with strain AH109 (Clon-
tech), which was tested for growth on Leu Trp Ade and Leu Trp His 
3-AT (2 mM) plates. Full-length Snf1 was cloned into pADH-Leu to generate
pADH-SNF1, which was used for complementation studies.
Indirect IF. pRS315-GLN3-MYC9 and pRS416-GLN3-MYC9 were trans-
formed into the wild-type or mutant strains (SZy159, SZy215, and SZy686).
These plasmids expressed GLN3-MYC9 at a level comparable to that in SZy158
(data not shown). In addition, these plasmids fully complemented the ability of
Gln3 to regulate GAP1 in the presence and absence of rapamycin (data not
shown). The above strains were grown into early log phase (optical density at 600
nm [OD600] 0.2) at 30°C in synthetic complete (SC) medium and then switched
to SC medium minus nitrogen (without ammonium sulfate and amino acids) or
SC medium minus glucose for 30 min at 30°C. The cells were fixed and then
stained with monoclonal antibody (MAb) 9E10, and indirect immunofluores-
cence (IF) was analyzed by fluorescence microscopy as described before (3).
Western blotting analysis, GST-pull down, and phosphatase treatment. Yeast
cells were harvested and lysed with glass beads in disruption buffer (DB) (50 mM
Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 50
mM -glycerophosphate, 10 mM NaF, 100 nM microcystin LR, 1 mM phenyl-
methylsulfonyl fluoride [PMSF], and a cocktail of protease inhibitors [Roche]) by
vortexing. Crude extracts were cleared by centrifugation twice at 20,800  g for
20 min. For Western blotting analysis, exponential-phase wild-type and mutant
yeast cultures (OD600  0.4) in SC medium (2% glucose) at 30°C were switched
to SC medium minus glucose. Protein samples (10 g) were used for gel elec-
trophoresis and detected by the ECL enhanced chemiluminescence system (Am-
ersham Life Sciences) with MAb 9E10 for Gln3-MYC9 or 12CA5 and anti-
polyhistidine antibodies (Sigma H1029) for HA (hemagglutinin)-Snf1 and Snf1,
respectively. In the glutathione S-transferase (GST)-pull down experiment, bac-
terial GST-Gln3 (3) immobilized to glutathione-agarose beads was incubated
with cell lysates of the wild-type and snf1 mutant cells. After extensive washing
with DB, the bound proteins were analyzed by Western blotting with an anti-His
antibody (Sigma) that recognizes the polyhistidine motif at the N terminus. For
the phosphatase treatment, cell extracts expressing Gln3-MYC9 were prepared
as described above with a modified DB (50 mM Tris-HCl [pH 7.5], 150 mM
NaCl, 1 mM EDTA, 10% glycerol, 0.5% NP-40, 10 nM calyculin A, 1 mM PMSF,
and a cocktail of protease inhibitors [Roche]). The cell extracts were then
incubated with calf intestine alkaline phosphatase (CIP) buffer alone, CIP (20 U
[Roche]), or CIP plus Na4P2O7 (10 mM) for 10 min at 30°C.
In vitro kinase assay. To purify active Snf1 from yeast, log-phase snf1 cells
expressing HA-Snf1 or carrying a control vector were shifted to low-glucose
conditions (0.05% glucose) for 1 h, lysed by glass beads in extraction buffer (50
mM HEPES [pH 7.5], 150 mM NaCl, 0.5% Triton X-100, 10% glycerol, 50 mM
imidazole, 1 mM PMSF, Roche Complete EDTA-free protease inhibitor tablet,
50 mM NaF, 10 mM -glycerophosphate). After being cleared by centrifugation
as described above, Snf1 was incubated with Ni-agarose beads (Qiagen) for 2 h
at 4°C and washed 5 times with extraction buffer containing 50 mM imidazole
and twice with kinase buffer (50 mM Tris [pH 7.5], 10 mM MgCl2, 1 mM
dithiothreitol, 20 M ATP). To assay for Snf1 kinase activity toward Gln3,
affinity-purified Snf1 was incubated in the presence of bacterial recombinant
GST-Gln3 (1 g) (3) and [-32P]ATP (5 Ci, 10 mCi/ml, 3,000 Ci/mM [Amer-
sham]) in the kinase buffer (25 l) for 30 min at 25°C. The phosphorylated
GST-Gln3 was analyzed by autoradiography.
Northern blotting analysis. Exponential wild-type and mutant yeast cultures
(OD600  0.4) in SC medium (2% glucose) at 30°C were switched to SC medium
minus glucose. A switch to SC medium containing a low concentration of glucose
(0.05%) gave essentially the same results (data not shown). Aliquots of yeast
cultures were withdrawn at different times. Total yeast RNA was prepared by the
phenol freezing extraction method (40). Total yeast RNA samples (20 g) were
separated on denaturing agarose gels, transferred onto nylon filters, hybridized
to 32P-labeled DNA probes, and detected by phosphorimaging as described
before (3).
RESULTS
Recent studies indicate that Gln3 localization is controlled
by nitrogen availability (2, 3). We found that Gln3 tagged at
the C terminus with a nine-MYC epitope (MYC9) primarily
localized in the cytoplasm when cells were cultured in SC
medium, but accumulated in the nucleus in the absence of
nitrogen (Fig. 1A) (2, 3). There was no staining with the non-
tagged strain (data not shown). For comparison, we also ex-
amined the localization of Gln3 in the absence of glucose or
both glucose and nitrogen. To our surprise, we also found that
glucose starvation led to rapid nuclear accumulation of Gln3
(Fig. 1A). Therefore, although Gln3 is known as a nitrogen
sensor in a broad sense, it is also under the control of glucose
availability. In essence, Gln3 cytoplasmic localization is a good
indicator of the level of preferred nutrients in the environment.
Regulation of Gln3 localization by glucose availability sug-
gested a role of glucose in the control of NCR gene expression.
To further explore this possibility, we performed Northern blot
analysis of several NCR genes. We found that glucose starva-
tion indeed caused an induction of GAP1, GDH2, and PUT1,
but not ACT1, the yeast actin gene (Fig. 1B). We next asked
whether Gln3 was required for NCR gene expression during
glucose limitation. We found that the gln3 mutation substan-
tially reduced, but did not completely abolish the expression of
GAP1, GDH2, and PUT1 (Fig. 1B), which was similar to that
during nitrogen starvation (3). We further investigated the role
of Gat1 during glucose limitation. We found that Gat1 was also
required for the full induction of GAP1. However, it was dis-
pensable for GDH2 induction. In addition, deletion of GAT1
actually enhanced the induction of PUT1. This effect of the
gat1 mutation was dependent on Gln3, since such an effect
was blocked by deletion of GLN3 (Fig. 1B). Hence, like Gln3,
Gat1 appears to participate in the regulation of NCR genes by
glucose. Its role, however, appears to be more complex.
Gln3 is phosphorylated in a TOR-dependent manner in pre-
ferred nitrogen, but becomes dephosphorylated under poor
nitrogen conditions or during nitrogen starvation (2, 3). We
therefore investigated whether glucose starvation affected the
level of Gln3 phosphorylation. As shown previously (2, 3),
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Gln3 appeared as several different phosphorylation forms
when grown in SC media, as indicated by its multiple mobility
forms on a sodium dodecyl sulfate-polyacrylamide gel (Fig. 2A,
lanes 1 through 3). Nitrogen starvation or rapamycin treatment
rapidly increased Gln3 gel mobility, eventually to a single, fully
dephosphorylated form (Fig. 2A, lanes 6 and 9). In contrast to
nitrogen starvation, however, glucose starvation further de-
creased the gel mobility of Gln3, suggesting that it became
additionally phosphorylated (Fig. 2A, lanes 11 and 12). To
confirm that this gel mobility change of Gln3 was due to phos-
phorylation, we treated the lysates of glucose-starved cells with
CIP. CIP treatment led to an increase in Gln3 gel mobility
(Fig. 2B, lane 4) that comigrated with the fastest form of Gln3
in the unstarved cells (Fig. 2B, lane 1). More importantly, such
a gel mobility increase was blocked by Na4P2O7, a potent CIP
inhibitor (Fig. 2B, lane 5), indicating that the Gln3 gel mobility
increase during glucose starvation was indeed due to phos-
phorylation. Gln3 phosphorylation by glucose limitation was
rapidly reversible once glucose was available (Fig. 2C), sug-
gesting that the phosphorylation or dephosphorylation status
of Gln3 can rapidly adapt to different glucose conditions. Gln3
also became phosphorylated when cells were switched from a
high glucose concentration (2%) to ethanol (nonfermentable
carbon source), raffinose (mimicking a low-glucose condition),
and galactose (Fig. 2D) or to a low glucose concentration
(0.05%) (data not shown). Thus, Gln3 phosphorylation is con-
trolled by a glucose repression mechanism.
That glucose limitation enhances Gln3 phosphorylation ar-
gues against a role of TOR in Gln3 phosphorylation, despite
the fact that TOR has been suggested in glucose signaling. To
further clarify this, we investigated whether TOR is involved in
FIG. 1. Glucose availability regulates subcellular localization of
Gln3 and Gln3-dependent NCR genes. (A) Glucose availability regu-
lates subcellular localization of Gln3. Early-log-phase cells (OD600 
0.2) expressing Gln3-MYC9 in SC medium containing 2% glucose
were switched to SC medium, SC medium minus glucose, or SC me-
dium minus nitrogen (SC medium minus ammonium sulfate and
amino acids) for 30 min. Gln3-MYC9 localization was then analyzed by
indirect IF staining with MAb 9E10. Nuclear DNA was stained with
4	,6-diamidino-2-phenylindole. The cell staining images were captured
with a SPOT digital camera. (B) Glucose availability regulates Gln3-
dependent NCR genes. Exponentially growing wild-type and mutant
yeast cells (OD600  0.4) in SC medium were switched to SC medium
minus glucose. Samples were withdrawn at different times and ana-
lyzed for expression of GAP1, GDH2, PUT1, and ACT1 by Northern
blot.
FIG. 2. Glucose availability regulates phosphorylation of Gln3.
(A) Glucose starvation decreases Gln3 gel mobility. Exponentially
growing cells in SC medium (OD600  0.4) were switched to SC
medium, SC medium plus rapamycin (SXCRAP), SC medium minus
nitrogen (SC-Nitrogen), or SC medium minus glucose (SC-glucose) for
0, 10, and 30 min. Gln3 gel mobility was detected by Western blotting.
(B) Electrophoretic decrease of Gln3 during glucose limitation is due
to phosphorylation. Exponential-phase yeast cells (OD600  0.4) in SC
medium (lane 1) were switched to SC medium minus glucose for 30
min (lane 2). Lysates of cells under glucose starvation were incubated
with a buffer for CIP (lanes 3 and 4) or CIP plus Na4P2O7 (lane 5).
Gln3 electrophoretic mobility was detected by Western blotting with
MAb 9E10. (C) Phosphorylation of Gln3 during glucose limitation is
reversible. Yeast cells cultured in SC medium minus glucose (SC-Glc)
were switched to SC medium for 10 and 30 min. Gln3 gel mobility was
detected by Western blotting. (D) Glucose limitation causes phosphor-
ylation of Gln3. Exponential cells in SC medium were switched to SC
medium plus glucose or SC medium containing one of the following
reagents as the sole carbon source for 30 min: ethanol, raffinose, or
galactose. Gln3 gel mobility was detected by Western blotting.
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Gln3 phosphorylation during glucose starvation. In this exper-
iment, we first treated exponentially growing cells in SC me-
dium (2% glucose) with rapamycin for 30 min, which led to
inhibition of TOR kinase activity (4) and complete dephos-
phorylation of Gln3 (Fig. 3, lanes 2 and 5). We then switched
the cells to medium containing rapamycin, but with or without
2% glucose. Gln3 remained in the dephosphorylated state un-
der the high-glucose condition (Fig. 3, lanes 5 through 7), but
became rapidly phosphorylated in the absence of glucose (Fig.
3, lanes 2 through 4). As expected, the tap42-11 mutation did
not have any effect on Gln3 phosphorylation in the presence or
absence of glucose (data not shown). Taken together with the
data shown in lanes 10 to 12 of Fig. 2A, these results indicate
that Gln3 becomes phosphorylated during glucose starvation,
regardless of whether rapamycin was present. Therefore, TOR
is not required for glucose signaling to regulate Gln3 phos-
phorylation. Our observation further suggests that the two
types of phosphorylations are independent events.
We have recently conducted a chemical genomics screen for
genes that, when deleted, confer resistance or sensitivity to
rapamycin (12). We have recently completed screening the
entire yeast genome. Like GLN3 and URE2, deletion of sev-
eral genes in the Snf1 pathway conferred significant differential
rapamycin sensitivity. Deletion of SNF1, the yeast AMPK and
SNF4, an activator of Snf1, rendered rapamycin resistance
(Fig. 4A). In contrast, deletion of REG1, a negative regulator
of Snf1, caused rapamycin hypersensitivity (Fig. 4A). These
results suggest that Snf1 negatively participates in a cellular
process that also involves TOR. We therefore examined
whether Snf1 was required for increased Gln3 phosphorylation
during glucose limitation. We found that the snf1 mutation
did not affect normal phosphorylation of Gln3 in SC medium
or dephosphorylation of Gln3 during nitrogen starvation (Fig.
4B) or rapamycin treatment (data not shown). However, the
snf1 mutation completely abolished the ability of Gln3 to
become phosphorylated in the absence of glucose (Fig. 4B).
These results demonstrate that Snf1 is required for glucose,
but not nitrogen, signaling to Gln3. To confirm this, we further
examined Gln3 phosphorylation during glucose limitation in
the snf1 strain that carried a plasmid-borne SNF1 or a vector
control. The plasmid-borne SNF1, but not the vector control,
was able to restore Gln3 phosphorylation upon glucose limi-
tation (Fig. 4C). In contrast, deletion of RGT2 and SNF3 did
not affect Gln3 phosphorylation under different nutrient con-
ditions (Fig. 4D). Therefore, the cytoplasmic, but not the cell
surface, glucose sensors regulate Gln3 phosphorylation or de-
phosphorylation, further supporting the hypothesis that Gln3
regulation is mediated by the glucose repression mechanism.
Snf1 is known to interact with several transcriptional regu-
lators, including Mig1 (34). Hence, we investigated a possible
interaction between Snf1 and Gln3 by using the yeast two-
hybrid system. We found that Gal4 DNA-binding domain
(BD)-Snf1 specifically interacted with Gal4 activation domain
(AD)-Gln3, but not with Gal4 AD alone (Fig. 5A). Conversely,
Gal4(AD)-Gln3 interacted with Gal4(BD)-Snf1, but not
Gal4(BD) alone (Fig. 5A). To further confirm the interaction
FIG. 3. TOR is not required for phosphorylation of Gln3 during
glucose limitation. Exponentially growing yeast cells in SC medium
(OD600  0.4) were treated with rapamycin for 30 min to generate
completely dephosphorylated Gln3. These cells were then switched to
SC medium with or without glucose in the presence of rapamycin for
10 and 30 min. Shown is the gel mobility of Gln3 as detected by
Western blotting.
FIG. 4. The role of glucose sensors in the in vivo phosphorylation
of Gln3. (A) Mutations in the Snf1 pathway confer differential rapa-
mycin sensitivity. The wild-type (WT) and mutant yeast strains were
streaked onto YPD and YPD plus rapamycin (YPDRAP) (25 nM)
plates and incubated at 30°C for 2 (YPD) and 4 (YPD plus rapamycin)
days, respectively. (B) Snf1 is required for Gln3 phosphorylation dur-
ing glucose starvation, but not during nitrogen starvation. Exponen-
tially growing wild-type and snf1 cells expressing Gln3-MYC9 in SC
medium (OD600  0.4) were switched to SC medium or SC medium
minus glucose or nitrogen for 30 min. (C) Recombinant Snf1 restores
the deficiency of Gln3 phosphorylation during glucose limitation in the
snf1 strain. The snf1 strains carrying a plasmid expressing recom-
binant Snf1 or a vector control were examined for Gln3-MYC9 phos-
phorylation at different times after glucose limitation. (Upper panel)
Western blot for Gln3-MYC9. (Lower panel) Western blot for Snf1.
(D) Rgt2 and Snf3 are not required for Gln3 phosphorylation during
glucose limitation. Exponentially growing wild-type and mutant cells
expressing Gln3-MYC9 in SC medium (OD600  0.4) were switched to
SC medium or SC medium minus nitrogen or glucose for 30 min. Gln3
phosphorylation was examined by Western blotting.
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between Snf1 and Gln3, we tested the ability of Snf1 to bind to
Gln3 in an in vitro GST-pull down assay (Fig. 5B). In this
experiment, we incubated lysates from the wild-type and snf1
strains with bacterially produced GST-Gln3 or GST. We found
that Snf1 specifically bound to GST-Gln3, but not to GST
alone (Fig. 5B). These results demonstrate that Snf1 and Gln3
are capable of binding to each other. In addition, Snf1 signif-
icantly phosphorylated a bacterial recombinant Gln3 in vitro
(Fig. 5C), suggesting that Snf1 may be directly responsible for
Gln3 phosphorylation in vivo .
To further confirm the role of Snf1 in glucose signaling to
Gln3, we performed indirect IF staining of Gln3-MYC9 in the
wild-type and snf1 cells. Gln3 primarily localized in the cyto-
plasm in both cell types in SC medium and accumulated in the
nucleus in the absence of nitrogen or glucose in the wild-type
strain (Fig. 6A). However, Gln3 remained in the cytoplasm
even in the absence of glucose in the snf1 strain (Fig. 6A). In
contrast, deletion of SNF1 did not affect the nuclear accumu-
lation of Gln3 during nitrogen starvation. Therefore, Snf1 is
required for nuclear accumulation during glucose, but not ni-
trogen starvation. We next investigated whether Snf1 was in-
volved in the regulation of NCR genes by Northern blot anal-
ysis of GAP1, GDH2, and PUT1. As seen earlier (Fig. 1B),
glucose limitation caused an induction of these genes in the
wild-type yeast (Fig. 6B). This induction, however, was virtually
absent in the snf1 mutant strain (Fig. 6B). Reg1 is a negative
regulator of Snf1, and deletion of REG1 causes constitutive
activation of Snf1 and derepression of many Snf1-regulated
genes (32). We found that the reg1 mutation caused consti-
tutive expression of GAP1 and GDH2 even in the presence of
2% glucose, further supporting the notion that Snf1 is a critical
regulator of NCR-sensitive genes via Gln3 and Gat1 (Fig. 6B).
Interestingly, the reg1 mutation only slightly delayed PUT1
induction, suggesting that additional factors in the Snf1 path-
way are required for Snf1-regulated PUT1 expression.
FIG. 5. Snf1 interacts with Gln3. (A) Snf1 interacts with Gln3 in a
yeast two-hybrid assay. Gal4 DNA binding domain (BD)-Snf1 specif-
ically interacts with Gal4 activation domain (AD)-Gln3, but not with
AD alone. The two-hybrid reporter strain (AH109) carrying different
BD and AD fusion plasmids was assayed for growth on an adenine
dropout plate or a histidine dropout plate containing 3-AT (2 mM).
LgT, large T antigen. (B) Snf1 binds to GST-Gln3. Extracts of wild-
type (WT) and snf1 yeast strains were assayed for their ability to bind
to immobilized, bacterially produced GST or GST-Gln3. The bound
materials were detected by Western blotting with an anti-polyhistidine
antibody that recognizes Snf1. (C) Snf1 phosphorylates Gln3 in vitro.
HA-Snf1 was immunoprecipitated and assayed for its ability to phos-
phorylate bacterial recombinant GST-Gln3 in the presence of [-32P]
ATP.
FIG. 6. Snf1 is required for Gln3 nuclear accumulation and induc-
tion of NCR genes during glucose limitation. (A) Early-log-phase
(OD600  0.2) wild-type (WT) or snf1 yeast cells expressing Gln3-
MYC9 in SC medium were switched to SC medium, SC medium minus
glucose (glucose), or SC medium minus nitrogen (Nitrogen) for 30
min. Gln3 localization was detected by indirect IF with the 9E10 MAb.
DAPI, 4	,6-diamidino-2-phenylindole. (B) Snf1 is required for expres-
sion of NCR genes during glucose limitation. Exponential wild-type or
mutant yeast cells (OD600  0.4) in SC medium were shifted to SC
medium minus glucose. Aliquots of culture were withdrawn at different
times (as shown) and analyzed for expression of selected NCR genes
by Northern blotting.
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There are two major glucose sensing and signaling mecha-
nisms in yeast: the one mediated by the cell surface glucose
sensors Rgt2 and Snf3, which belong to the glucose transporter
family, also called the glucose induction mechanism (recently
reviewed in reference 35); and the one mediated by the cyto-
plasmic glucose sensor Snf1, also called the glucose repression
mechanism (recently reviewed in references 8, 21, and 22).
Similarly, nitrogen sensing and signaling also involve two dis-
tinct sensors. The cell surface amino acid sensor Ssy1 is related
to amino acid permeases and acts analogously to Rgt2 and
Snf3 (19, 25, 26). On the other hand, Tor1 and Tor2 are the
cytoplasmic nitrogen sensors. The role of Gln3 in nitrogen
sensing and signaling is dependent on TOR proteins, but not
Ssy1 (P. G. Bertram and X. F. S. Zheng, unpublished obser-
vation). In this study, we show that Gln3 is regulated by Snf1
(this study), but not Snf3 and Rgt2 (Fig. 4D), the two cell
surface glucose sensors (31, 36). Therefore, regulation of Gln3
by both nitrogen and glucose utilizes very similar strategies (for
a model, see Fig. 7). In addition to regulating Gln3 nuclear
accumulation, phosphorylation may also modulate the ability
of Gln3 to transactivate NCR genes, since there is a quantita-
tive difference in GAP1 expression levels under different con-
ditions. The GAP1 induction level was much higher during
nitrogen starvation (
100-fold) (3) than during glucose star-
vation (
11.5-fold) (Fig. 1B).
Both TOR and Snf1 are cytoplasmic kinases that control the
phosphorylation of Gln3 in response to different nutrients.
However, phosphorylation by these two kinases has opposite
effects. TOR-dependent phosphorylation is consistent with its
role in keeping Gln3 in the cytoplasm (2, 3). In contrast,
Snf1-dependent phosphorylation correlates well with increased
nuclear accumulation (this study). The opposing effects of the
two different phosphorylations also suggest that TOR-depen-
dent and Snf1-dependent phosphorylation events occur at dis-
tinct sites. Two additional observations further support this
hypothesis. Inhibition of TOR by rapamycin treatment did not
affect glucose limitation-dependent phosphorylation. In con-
trast, deletion of Snf1 had little effect on the phosphorylation
or dephosphorylation events under different nitrogen condi-
tions. Snf1-dependent phosphorylation may promote Gln3 nu-
clear import and/or inhibit Gln3 export (Fig. 7). The TOR- and
Snf1-dependent phosphorylation sites need to be identified in
order to clearly define their roles in the regulation of Gln3
localization and functions.
Why does the cell need to up-regulate NCR-sensitive genes
during glucose limitation? Both carbon- and nitrogen-contain-
ing compounds can be ultimately utilized for energy metabo-
lism as well as metabolic biosyntheses. For example, while
glycolysis and the TCA cycle use glucose to generate NADH
leading to ATP synthesis, many of the intermediate products
are also precursors for biosynthesis of amino acids, nucleo-
tides, and lipids (1). These genes are induced by rapamycin or
nitrogen starvation (23). Conversely, amino acids can be used
as precursors for biosynthesis of other amino acids, nucleo-
tides, and lipids as well as for energy metabolism. For example,
GDH2 encodes glutamate dehydrogenase that catalyzes the
conversion of glutamate and NAD to -ketoglutarate, NH4
,
and NADH. While NADH is directly used to generate ATP,
-ketoglutarate can be directly fed into the TCA cycle. During
glucose limitation, the cell may need to mobilize other avail-
able nutrients as alternative carbon sources, including amino
acids. In addition to energy metabolism and metabolic biosyn-
theses, nitrogen and glucose starvation results in many other
common cell physiological changes, such as exit from the cell
cycle, accumulation of glycogen, reduced protein synthesis, and
increased autophagy. For example, limitation of both nitrogen
and glucose leads to increased expression of several genes
required for autophagy, including APG and vacuolar protease
genes (11, 41), as well as those involved in ribosomal biogen-
esis (30). Therefore, in addition to regulation of NCR genes,
Gln3 appears to be important for general starvation responses
as well.
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